Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.06

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.06). Revenue for the quarter came in at $8.3 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
• Lobe Sciences Ltd. Announces Closing of Upsize to Non-Brokered Private Placement
• Li Auto reports 37,679 vehicle deliveries in August 2026